Literature DB >> 29344210

MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2.

Quan'e Kan1, Yong Su1, Huihui Yang1.   

Abstract

MicroRNAs (miRs) are a group of short, endogenous, non-protein-coding and single-stranded RNAs that regulate gene expression by binding to the 3'-untranslated region (3'UTR) of mRNAs, which results in their degradation or translational repression. The aim of the present study was to investigate the expression and function of miR-335 in human papillary thyroid cancer (PTC). Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to quantify the relative miR-335 expression levels in PTC tissues and cell lines. The effect of miR-335 on the proliferation, migration and invasion of PTC cells was assessed by an MTT assay, and transwell migration and invasion assays, respectively. Dual-luciferase reporter assays were employed to explore whether miR-335 directly targeted the 3'UTR of the potential target gene zinc finger E-box binding homeobox 2 (ZEB2). RT-qPCR and western blotting were adopted to assess the effect of miR-335 on the mRNA and protein expression of ZEB2. RT-qPCR revealed that miR-335 was downregulated in PTC tissues and cell lines. The MTT assay and transwell migration and invasion assays demonstrated that the overexpression of miR-335 significantly inhibited the proliferation, migration and invasion of PTC cells. ZEB2 was identified as a direct target of miR-335 with computational analysis, which was confirmed with a dual-luciferase reporter assay, RT-qPCR and western blotting. The knockdown of ZEB2 significantly inhibited the proliferation, migration and invasion of PTC cells, indicating that ZEB2 may be a functional target of miR-335. Taken together, these findings suggested that miR-335 functioned as a tumor suppressor and suppressed the growth and metastatic behavior of PTC cells by targeting ZEB2.

Entities:  

Keywords:  growth; metastasis; microRNA-335; papillary thyroid cancer; thyroid cancer; zinc finger E-box binding homeobox 2

Year:  2017        PMID: 29344210      PMCID: PMC5755184          DOI: 10.3892/ol.2017.7126

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  45 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.

Authors:  Adriana Sondermann; Flavia Maziero Andreghetto; Ana Carolina Bernardini Moulatlet; Elivane da Silva Victor; Marilia Germanos de Castro; Fábio Daumas Nunes; Lenine Garcia Brandão; Patricia Severino
Journal:  Clin Exp Metastasis       Date:  2015-05-26       Impact factor: 5.150

3.  MicroRNA dysregulation in human thyroid cells following exposure to ionizing radiation.

Authors:  Marina N Nikiforova; Manoj Gandhi; Manoj Gandi; Lindsey Kelly; Yuri E Nikiforov
Journal:  Thyroid       Date:  2011-02-16       Impact factor: 6.568

4.  MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1.

Authors:  Ji Qi; Shawn J Rice; Anna C Salzberg; E Aaron Runkle; Jason Liao; Dani S Zander; David Mu
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

5.  MicroRNAs in metabolism and metabolic diseases.

Authors:  V Rottiers; S H Najafi-Shoushtari; F Kristo; S Gurumurthy; L Zhong; Y Li; D E Cohen; R E Gerszten; N Bardeesy; R Mostoslavsky; A M Näär
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-12-12

6.  MiR-99a Inhibits Cell Proliferation and Tumorigenesis through Targeting mTOR in Human Anaplastic Thyroid Cancer.

Authors:  Hou-Gang Huang; Xi Luo; Shuai Wu; Bin Jian
Journal:  Asian Pac J Cancer Prev       Date:  2015

7.  Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.

Authors:  Chen-Kai Chou; Kuender D Yang; Fong-Fu Chou; Chao-Cheng Huang; Yueh-Wen Lan; Ya-Fang Lee; Hong-Yo Kang; Rue-Tsuan Liu
Journal:  J Clin Endocrinol Metab       Date:  2012-12-21       Impact factor: 5.958

8.  Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection.

Authors:  Brian Hung-Hin Lang; Kai Pun Wong; Koon Yat Wan; Chung-Yau Lo
Journal:  Ann Surg Oncol       Date:  2011-10-12       Impact factor: 5.344

9.  MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1.

Authors:  Y Xu; F Zhao; Z Wang; Y Song; Y Luo; X Zhang; L Jiang; Z Sun; Z Miao; H Xu
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

10.  BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor.

Authors:  Haitao Zheng; Meng Wang; Lixin Jiang; Haidi Chu; Jinchen Hu; Jinyao Ning; Baoyuan Li; Dong Wang; Jie Xu
Journal:  Cancer Res Treat       Date:  2015-08-12       Impact factor: 4.679

View more
  9 in total

Review 1.  MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.

Authors:  Amir Abbas Hamidi; Negin Taghehchian; Zahra Basirat; Amir Sadra Zangouei; Meysam Moghbeli
Journal:  Biomark Res       Date:  2022-06-04

2.  PKM2 functions as a potential oncogene and is a crucial target of miR-148a and miR-326 in thyroid tumorigenesis.

Authors:  Gang Yu; Weili Sun; Yong Shen; Yongquan Hu; Henchao Liu; Weipeng Li; Yong Wang
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

3.  MicroRNA‑30a regulates cell proliferation, migration, invasion and apoptosis in human nasopharyngeal carcinoma via targeted regulation of ZEB2.

Authors:  Xi Chen; Junzheng Li; Shifen Zhang; Weiping Xu; Dianyu Shi; Mugai Zhuo; Shaoqin Liang; Wenbin Lei; Chun Xie
Journal:  Mol Med Rep       Date:  2019-06-14       Impact factor: 2.952

4.  Emerging roles of the long non-coding RNA 01296/microRNA-143-3p/MSI2 axis in development of thyroid cancer.

Authors:  Zheng-Lin Wang; Cong Wang; Wei Liu; Zhi-Long Ai
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.976

5.  Low microRNA-622 expression predicts poor prognosis and is associated with ZEB2 in glioma.

Authors:  Qian Song; Honggang Pang; Lei Qi; Chen Liang; Tuo Wang; Wei Wang; Ruichun Li
Journal:  Onco Targets Ther       Date:  2019-09-10       Impact factor: 4.147

Review 6.  MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy.

Authors:  Milad Ashrafizadeh; Hui Li Ang; Ebrahim Rahmani Moghadam; Shima Mohammadi; Vahideh Zarrin; Kiavash Hushmandi; Saeed Samarghandian; Ali Zarrabi; Masoud Najafi; Reza Mohammadinejad; Alan Prem Kumar
Journal:  Biomolecules       Date:  2020-07-12

Review 7.  MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment.

Authors:  Maria Papaioannou; Angeliki G Chorti; Anthoula Chatzikyriakidou; Kleanthis Giannoulis; Sohail Bakkar; Theodosios S Papavramidis
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

8.  MicroRNA‑3666 suppresses the growth and migration of glioblastoma cells by targeting KDM2A.

Authors:  Taotao Shou; Huyin Yang; Jia Lv; Dai Liu; Xiaoyang Sun
Journal:  Mol Med Rep       Date:  2018-11-27       Impact factor: 2.952

9.  An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer.

Authors:  Wanwan Yi; Jin Liu; Shuping Qu; Hengwei Fan; Zhongwei Lv
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.